Increased plasma advanced oxidation protein products is an early marker of endothelial dysfunction in type 2 diabetes patients without albuminuria

Journal of Diabetes

Volumn 6, Issue 5, 2014, Pages 417-426

  Liang, Min ^a,b   Wang, Jun ^a,b   Xie, Chao ^a,b   Yang, Yan ^a   Tian, Jian Wei ^a,b   Xue, Yao Ming ^a   Hou, Fan Fan ^a,b  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

^b State Key Laboratory of Organ Failure Research National Clinical Center of Kidney Disease   (China)

Author keywords

Advanced oxidation protein products; Endothelial dysfunction; Normoalbuminuria; Type 2 diabetes

Indexed keywords

6 N CARBOXYMETHYLLYSINE; ADVANCED OXIDATION PROTEIN PRODUCT; ALBUMIN; C REACTIVE PROTEIN; CREATININE; GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INTERCELLULAR ADHESION MOLECULE 1; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; URIC ACID; BIOLOGICAL MARKER; ICAM1 PROTEIN, HUMAN;

ADULT; ALBUMINURIA; ARTICLE; BLOOD FLOW VELOCITY; BRACHIAL ARTERY; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CROSS-SECTIONAL STUDY; ENDOTHELIAL DYSFUNCTION; FEMALE; GLUCOSE METABOLISM; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SPECTROPHOTOMETRY; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; URIC ACID BLOOD LEVEL; VASODILATATION; BLOOD; CASE CONTROL STUDY; CLINICAL TRIAL; COMPLICATION; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; EARLY DIAGNOSIS; METABOLISM; MIDDLE AGED; MULTICENTER STUDY; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PREDICTIVE VALUE; RISK FACTOR; UPREGULATION; VASCULAR ENDOTHELIUM;

ADULT; ADVANCED OXIDATION PROTEIN PRODUCTS; ALBUMINURIA; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; EARLY DIAGNOSIS; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; MALE; MIDDLE AGED; OXIDATIVE STRESS; PREDICTIVE VALUE OF TESTS; RISK FACTORS; UP-REGULATION; VASODILATION;

EID: 84906214933     PISSN: 17530393     EISSN: 17530407     Source Type: Journal    
DOI: 10.1111/1753-0407.12134     Document Type: Article

References (26)

1. International Diabetes Federation. IDF Diabetes Atlas, 3rd edn. IDF, Brussels, 2006.
2. Woodward M, Zhang X, Barzi F etal. The effects of diabetes on the risks of major cardiovascular diseases and death in the Asia-Pacific region. Diabetes Care. 2003; 26: 360-366.
3. Munzel T, Sinning C, Post F etal. Pathophysiology, diagnosis and prognostic implications of endothelial dysfunction. Ann Med. 2008; 40: 180-196.
4. Hadi HA, Suwaidi JA. Endothelial dysfunction in diabetes mellitus. Vasc Health Risk Manag. 2007; 3: 853-876.
5. Garg JP, Bakris GL. Microalbuminuria: Marker of vascular dysfunction, risk factor for cardiovascular disease. Vasc Med. 2002; 7: 35-43.
6. Lim SC, Caballero AE, Smakowski P etal. Soluble intercellular adhesion molecule, vascular cell adhesion molecule, and impaired microvascular reactivity are early markers of vasculopathy in type 2 diabetic individuals without microalbuminuria. Diabetes Care. 1999; 22: 1865-1870.
7. Baynes JW, Thorpe SR. Role of oxidative stress in diabetic complications: A new perspective on an old paradigm. Diabetes. 1999; 48: 1-9.
8. Jay D, Hitomi H, Griendling KK. Oxidative stress and diabetic cardiovascular complications. Free Radic Biol Med. 2006; 40: 183-192.
9. Coppo R, Camilla R, Amore A, Peruzzi L. Oxidative stress in IgA nephropathy. Nephron Clin Pract. 2010; 116: c196-c198.
10. Kalousova M, Skrha J, Zima T. Advanced glycation end-products and advanced oxidation protein products in patients with diabetes mellitus. Physiol Res. 2002; 51: 597-604.
11. Martin-Gallan P, Carrascosa A, Gussinye M, Dominguez C. Biomarkers of diabetes-associated oxidative stress and antioxidant status in young diabetic patients with or without subclinical complications. Free Radic Biol Med. 2003; 34: 1563-1574.
12. Guo ZJ, Niu HX, Hou FF etal. Advanced oxidation protein products activate vascular endothelial cells via a RAGE-mediated signaling pathway. Antioxid Redox Signal. 2008; 10: 1699-1712.
13. Liu SX, Hou FF, Guo ZJ etal. Advanced oxidation protein products accelerate atherosclerosis through promoting oxidative stress and inflammation. Arterioscler Thromb Vasc Biol. 2006; 26: 1156-1162.
14. Corretti MC, Anderson TJ, Benjamin EJ etal. Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: A report of the International Brachial Artery Reactivity Task Force. J Am Coll Cardiol. 2002; 39: 257-265.
15. Deanfield JE, Halcox JP, Rabelink TJ. Endothelial function and dysfunction: Testing and clinical relevance. Circulation. 2007; 115: 1285-1295.
16. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2002; 35 (Suppl.) S64-S71.
17. Feng JX, Hou FF, Liang M etal. Restricted intake of dietary advanced glycation end products retards renal progression in the remnant kidney model. Kidney Int. 2007; 71: 901-911.
18. Ceriello A, Motz E. Is oxidative stress the pathogenic mechanism underlying insulin resistance, diabetes, and cardiovascular disease? The common soil hypothesis revisited. Arterioscler Thromb Vasc Biol. 2004; 24: 816-823.
19. Harrison D, Griendling KK, Landmesser U etal. Role of oxidative stress in atherosclerosis. Am J Cardiol. 2003; 91: 7-11.
20. Lum H, Roebuck KA. Oxidant stress and endothelial cell dysfunction. Am J Physiol Cell Physiol. 2001; 280: C719-C741.
21. Kocak H, Gumuslu S, Ermis C etal. Oxidative stress and asymmetric dimethylarginine is independently associated with carotid intima media thickness in peritoneal dialysis patients. Am J Nephrol. 2008; 28: 91-96.
22. Yang XB, Hou FF, Wu Q etal. Increased levels of advanced oxidation protein products are associated with atherosclerosis in chronic kidney disease. Zhonghua Nei Ke Za Zhi. 2005; 44: 342-346 (in Chinese).
23. Ninomiya T, Perkovic V, de Galan BE etal. Albuminuria and kidney function independently predict cardiovascular and renal outcomes in diabetes. J Am Soc Nephrol. 2009; 20: 1813-1821.
24. Gerstein HC, Mann JF, Yi Q etal. Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals. JAMA. 2001; 286: 421-426.
25. Dogra G, Rich L, Stanton K, Watts GF. Endothelium-dependent and independent vasodilation studies at normoglycaemia in type I diabetes mellitus with and without microalbuminuria. Diabetologia. 2001; 44: 593-601.
26. Bonetti PO, Lerman LO, Lerman A. Endothelial dysfunction: A marker of atherosclerotic risk. Arterioscler Thromb Vasc Biol. 2003; 23: 168-175.